Clinical Trials on Carcinoma, Ovarian Epithelial
Total 30937 results
-
Hunan Cancer HospitalUnknown
-
AbbVie (prior sponsor, Abbott)CompletedOvarian CancerUnited States, Australia, Canada, Hungary, Israel, New Zealand, Poland, United Kingdom
-
Women and Infants Hospital of Rhode IslandCompletedOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
Onconova Therapeutics, Inc.Completed
-
Genentech, Inc.Completed
-
EMD SeronoCompletedOvarian CancerUnited States
-
Daniela Matei, MDBayer; Hoosier Cancer Research NetworkTerminated
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedOvarian CancerUnited States
-
Henry M. Jackson Foundation for the Advancement...NovartisCompletedOvarian Cancer | Primary Peritoneal CancerUnited States
-
CASI Pharmaceuticals, Inc.CompletedOvarian Cancer | Peritoneal Cancer | Fallopian CancerUnited States, Canada
-
Hoffmann-La RocheCompletedOvarian CancerEl Salvador
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownOvarian Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
University of Alabama at BirminghamCompleted
-
Cancer Research UKUnknown
-
University of Alabama at BirminghamNational Cancer Institute (NCI)WithdrawnOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Loyola UniversityCompletedOvarian CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
Astellas Pharma IncAgensys, Inc.TerminatedCarcinoma | Ovarian Diseases | Ovarian Neoplasms | Ovarian CancerUnited States
-
NYU Langone HealthNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedOvarian CancerUnited States
-
European Organisation for Research and Treatment...CompletedOvarian CancerFrance, Spain, United Kingdom, Belgium, Israel, Switzerland, Italy
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
University of ArizonaNational Cancer Institute (NCI)CompletedOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
Ottawa Hospital Research InstituteCompleted
-
CASI Pharmaceuticals, Inc.CompletedOvarian CancerUnited States
-
North Eastern German Society of Gynaecological...CompletedOvarian CancerGermany
-
Yonsei UniversityRecruitingOvarian CancerKorea, Republic of
-
The Christie NHS Foundation TrustNot yet recruitingOvarian Cancer | Chemotherapy | Surgery | Patient Reported Outcome Measure
-
The Affiliated Hospital of Xuzhou Medical UniversityXuzhou Medical University; IIT MediTech (Jiangsu) Co. LtdRecruiting
-
Tongji HospitalSun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Qilu... and other collaboratorsNot yet recruiting
-
Xiaoxiang ChenRecruitingOvarian Cancer | PARP Inhibitor | Clinical MarkerChina
-
Hoffmann-La RocheCompletedOvarian CancerBelgium, Denmark, France, Germany, Portugal, Spain, Turkey, Bosnia and Herzegovina, Italy, Sweden, Finland, Netherlands, Norway, Greece
-
University Health Network, TorontoAstraZenecaCompleted
-
Ganymed Pharmaceuticals GmbHCompletedOvarian CancerBelgium, Germany
-
NCIC Clinical Trials GroupCompletedOvarian CancerUnited States, Canada, United Kingdom
-
Astellas Pharma IncCompletedOvarian Cancer | Solid TumorsUnited States, United Kingdom, Australia, Canada, Switzerland, Czechia, Italy, Poland, Romania, Russian Federation
-
Carilion ClinicGlaxoSmithKlineWithdrawn
-
Charles University, Czech RepublicUnknown
-
AGC Biologics S.p.A.Completed
-
Angle plcMedical University of Vienna; Charite University, Berlin, Germany; Vivantes Netzwerk...CompletedEvaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.Ovarian NeoplasmsGermany, Austria
-
AGC Biologics S.p.A.CompletedOvarian CancerItaly, United Kingdom
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Hoffmann-La RocheCompletedOvarian CancerItaly, Austria, Belgium, France, Germany, Spain, Netherlands, Sweden, Denmark, Norway
-
Verastem, Inc.CompletedOvarian CancerUnited States
-
Genzyme, a Sanofi CompanyTerminatedOvarian CancerGermany
-
National University Hospital, SingaporeUnknownOvarian CancerSingapore